The San Diego MIT Enterprise Forum hosts AltheaDx CEO Franscois Ferre in this case study of a new paradigm for personalized medicine. While personalized medicine holds the potential to create a new standard of healthcare, there are challenges: How can companies earn revenue in this undertaking? What are the likely challenges for and objections from big pharma companies? Will the current economy and healthcare reform impact this emerging market? A reception and registration begins at 5 p.m. More information and online registration is available here.